HomeInsights52 Week High Stocks

Mankind Pharma Ltd 52 Week High

Mankind Pharma Ltd 52 Week High

stocks purchased

₹ 4.2 Cr

Volume Transacted

(Nov 7, 2024)

stocks purchased

15.6 K

Stocks Traded

(Nov 7, 2024)

Last Updated on: Nov 08, 2024

Image

Mankind Pharma Ltd

NSE: MANKIND

YEARHIGH

₹ 2882.75

Last updated on: Nov 07, 2024

Key Highlights

  • The 52 Week HIGH of Mankind Pharma Ltd is ₹ 2882 as of 07 Nov 24.

Company Fundamentals for Mankind Pharma Ltd

No data available

Market Price Over Time

1M

1Y

3Y

5Y

Monitoring Mankind Pharma Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
07 Nov 20242726.45
06 Nov 20242750.1
05 Nov 20242714.4
04 Nov 20242734.95
01 Nov 20242690.55
31 Oct 20242666.6
30 Oct 20242628.25
29 Oct 20242527.35
28 Oct 20242428.6
25 Oct 20242456.95

Asset Value vs Market Value of Mankind Pharma Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Historical Revenue of Mankind Pharma Ltd

No data available

* All values are in crore

Historical Net Profit of Mankind Pharma Ltd

No data available

* All values are in crore

Mankind Pharma Ltd News Hub

News

Mankind Pharma receives reaffirmation in credit rating from CRISIL

Mankind Pharma has received reaffirmation in credit ratings from CRISIL as under: Commerci...

Read more

06 Nov 202413:15

News

Mankind Pharma hits life high after Q2 PAT jumps 30% YoY to Rs 653 cr

Profit before tax was at Rs 849.32 crore in Q2 FY25, registering a growth of 32.5% from Rs...

Read more

06 Nov 202410:03

News

Mankind Pharma Ltd spurts 0.01%, up for fifth straight session

Mankind Pharma Ltd is up for a fifth straight session today. The stock is quoting at Rs 26...

Read more

04 Nov 202413:00

News

Mankind Pharma Ltd spurts 3.89%

Mankind Pharma Ltd is up for a third straight session in a row. The stock is quoting at Rs...

Read more

31 Oct 202413:05

News

Mankind Pharma to convene board meeting

Mankind Pharma will hold a meeting of the Board of Directors of the Company on 5 November ...

Read more

25 Oct 202416:07

News

Mankind Pharma receives ratings action from ICRA

Mankind Pharma has received reaffirmation in credit rating for non-convertible debentures ...

Read more

30 Sep 202417:14

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for 52 Week High of Mankind Pharma Ltd

What is the significance of Mankind Pharma Ltd reaching its 52-week high?

Mankind Pharma Ltd reaching its 52-week high indicates strong market confidence and a positive outlook on the company's financial health and growth prospects. This milestone often reflects successful business performance and can boost investor sentiment.

Why do investors monitor Mankind Pharma Ltd 52-week high?

Investors monitor Mankind Pharma Ltd 52-week high to gauge the stock's peak performance and overall market strength, which can indicate robust financial health and growth potential. It also helps them assess if the stock is trading near its maximum value, influencing decisions on buying, holding, or selling.

Is Mankind Pharma Ltd a good buy when it hits its 52-week high?

Whether Mankind Pharma Ltd is a good buy at its 52-week high depends on various factors, including the company's future growth prospects, overall market conditions, individual investment strategies, and other important Mankind Pharma Ltd fundamentals.

What should I consider before investing in Mankind Pharma Ltd at its 52-week high?

Before investing in Mankind Pharma Ltd at its 52-week high, consider evaluating the company's recent financial performance, growth potential, and overall market conditions to ensure it aligns with your investment goals. Additionally, assess whether the stock's current valuation justifies the potential for future returns and if it fits your risk tolerance.

Can Mankind Pharma Ltd stock price continue to rise after reaching its 52-week high?

Mankind Pharma Ltd stock price can continue to rise after reaching its 52-week high if it maintains strong fiscal performance and favorable market conditions. However, future growth depends on numerous factors such as company earnings, industry trends, and broader economic conditions.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*